跳至主要内容
临床试验/NCT01182402
NCT01182402已完成不适用

Electronic Compliance Monitoring in Opioid Substitution Treatment

Kuopio University Hospital2 个研究点 分布在 1 个国家目标入组 37 人开始时间: 2010年9月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
37
试验地点
2
主要终点
The effectiveness of treatment (Treatment Outcomes Profile TOP)

研究概览

简要总结

The purpose of this study is to improve unsupervised dosing of opioid substitution medications. The aim of the study is to examine whether electronic compliance monitoring provides some advantages to patients'treatment and what kind of patients especially benefit from monitoring. We would also like to know if electronic compliance monitoring can prevent the abuse/diversion of medications and how implementing this method to wider treatment facilities succeeds.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • opiate dependence F11.22 according to ICD-10
  • Suboxone treatment
  • the duration of substitution treatment before study at least one month
  • stable medication dose

排除标准

  • unstable situation in life according to treatment staff's opinions

结局指标

主要结局

The effectiveness of treatment (Treatment Outcomes Profile TOP)

时间窗: Every two months.

Structured interview designed to measure the effectiveness and outcomes of opioid substitution treatment.

次要结局

  • Patients´opinions about the treatment.(Once when the study phase ends (after four months).)

研究者

发起方
Kuopio University Hospital
申办方类型
Other

研究点 (2)

Loading locations...

相似试验